Literature DB >> 12668282

Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice.

Nachi Harada1, Noriko Kodama, Hiroaki Nanba.   

Abstract

Dendritic cells (DCs) are known to not only induce the activation of T cells, but are also associated with the differentiation of T cells. The D-fraction, a beta-glucan extracted from maitake (Grifola frondosa) which expresses anti-tumor effects by establishing a helper (Th)-1 dominance in BALB/c mice, enhanced IL-12p70 production by DCs, when the ratio of CD8alpha(+) DCs to CD8alpha(-) DCs increased. In addition, examination of the tumor rejection effect of D-fraction-stimulated DCs loaded with tumor antigen revealed that tumor growth is inhibited completely by activating CD4(+) T cells and CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668282     DOI: 10.1016/s0304-3835(02)00716-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production.

Authors:  Hong Lin; Sandy W Y Cheung; Mirjana Nesin; Barrie R Cassileth; Susanna Cunningham-Rundles
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

2.  Surgical resection of stage IV colorectal cancer and prognosis.

Authors:  Hiroshi Katoh; Keishi Yamashita; Yukihito Kokuba; Takeo Satoh; Heita Ozawa; Kazuhiko Hatate; Atsushi Ihara; Takatoshi Nakamura; Wataru Onosato; Masahiko Watanabe
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

3.  Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy.

Authors:  Sensuke Konno
Journal:  Int J Gen Med       Date:  2009-07-30

Review 4.  Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology.

Authors:  Alena G Guggenheim; Kirsten M Wright; Heather L Zwickey
Journal:  Integr Med (Encinitas)       Date:  2014-02

5.  A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects.

Authors:  Gary Deng; Hong Lin; Andrew Seidman; Monica Fornier; Gabriella D'Andrea; Kathleen Wesa; Simon Yeung; Susanna Cunningham-Rundles; Andrew J Vickers; Barrie Cassileth
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-01       Impact factor: 4.553

Review 6.  Antiinflammatory and immunomodulating properties of fungal metabolites.

Authors:  Cristina Lull; Harry J Wichers; Huub F J Savelkoul
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

7.  Orally administered β-glucan attenuates the Th2 response in a model of airway hypersensitivity.

Authors:  Ashley R Burg; Laura Quigley; Adam V Jones; Geraldine M O'Connor; Kimberly Boelte; Daniel W McVicar; Selinda J Orr
Journal:  Springerplus       Date:  2016-06-21

8.  Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells.

Authors:  Eliana Noelia Alonso; María Julia Ferronato; María Eugenia Fermento; Norberto Ariel Gandini; Alejandro López Romero; Josefina Alejandra Guevara; María Marta Facchinetti; Alejandro Carlos Curino
Journal:  Oncotarget       Date:  2018-05-04

Review 9.  Immunomodulatory functional foods and their molecular mechanisms.

Authors:  Jae Hwan Kim; Da Hyun Kim; Seongin Jo; Min Je Cho; Ye Ryeong Cho; Yong Joon Lee; Sanguine Byun
Journal:  Exp Mol Med       Date:  2022-01-25       Impact factor: 12.153

10.  Immunomodulating Activity of Agaricus brasiliensis KA21 in Mice and in Human Volunteers.

Authors:  Ying Liu; Yasushi Fukuwatari; Ko Okumura; Kazuyoshi Takeda; Ken-Ichi Ishibashi; Mai Furukawa; Naohito Ohno; Kazu Mori; Ming Gao; Masuro Motoi
Journal:  Evid Based Complement Alternat Med       Date:  2008-06       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.